You May Also Like

Eli Lilly close to buying gene editing firm Verve for $1.3 bln- FT

US and UK announce a trade deal, but steel imports unresolved

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

OpenAI executives have discussed accusing Microsoft of anticompetitive behavior, WSJ reports

Nelson Tanure hires Rothschild for Braskem bid talks

Wells Fargo upgrades Wix as it sees scope for price increases